Asia: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Asia

The Asian medicaments containing insulin market rose rapidly to $X in 2021, increasing by 9.4% against the previous year. Overall, consumption, however, saw a abrupt decrease. Over the period under review, the market reached the peak level at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Asia

In value terms, medicaments containing insulin production shrank modestly to $X in 2021 estimated in export price. Over the period under review, production, however, recorded a pronounced reduction. The most prominent rate of growth was recorded in 2013 when the production volume increased by 12% against the previous year. As a result, production reached the peak level of $X. From 2014 to 2021, production growth remained at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Asia

After three years of growth, overseas shipments of medicaments containing insulin but not antibiotics decreased by -36.1% to X tons in 2021. Over the period under review, exports showed a deep setback. The most prominent rate of growth was recorded in 2020 with an increase of 110% against the previous year. The volume of export peaked at X tons in 2013; however, from 2014 to 2021, the exports stood at a somewhat lower figure.

In value terms, medicaments containing insulin exports contracted dramatically to $X in 2021. In general, exports saw a precipitous decrease. The growth pace was the most rapid in 2020 when exports increased by 81%. Over the period under review, the exports reached the peak figure at $X in 2013; however, from 2014 to 2021, the exports failed to regain momentum.

Exports by Country

Thailand dominates exports structure, reaching X tons, which was near 74% of total exports in 2021. The United Arab Emirates (X tons) ranks second in terms of the total exports with a 9.4% share, followed by Jordan (7.8%). India (X tons) and Hong Kong SAR (X tons) followed a long way behind the leaders.

Thailand was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +102.4% from 2012 to 2021. At the same time, Hong Kong SAR (+70.1%) and Jordan (+1.7%) displayed positive paces of growth. By contrast, the United Arab Emirates (-6.7%) and India (-35.1%) illustrated a downward trend over the same period. Thailand (+74 p.p.), Jordan (+5.1 p.p.), Hong Kong SAR (+2.5 p.p.) and the United Arab Emirates (+2.2 p.p.) significantly strengthened its position in terms of the total exports, while India saw its share reduced by -81.2% from 2012 to 2021, respectively.

In value terms, Thailand ($X), the United Arab Emirates ($X) and Jordan ($X) were the countries with the highest levels of exports in 2021, together comprising 87% of total exports. Hong Kong SAR and India lagged somewhat behind, together accounting for a further 5.6%.

In terms of the main exporting countries, Hong Kong SAR, with a CAGR of +99.7%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced mixed trends in the exports figures.

Export Prices by Country

The export price in Asia stood at $X per ton in 2021, with an increase of 13% against the previous year. Overall, the export price, however, faced a abrupt downturn. The most prominent rate of growth was recorded in 2016 when the export price increased by 28% against the previous year. Over the period under review, the export prices reached the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Hong Kong SAR (+17.4%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Insulin Imports

Imports in Asia

In 2021, the amount of medicaments containing insulin but not antibiotics imported in Asia dropped modestly to X tons, approximately mirroring the previous year. In general, imports saw a deep reduction. The most prominent rate of growth was recorded in 2016 when imports increased by 67%. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports surged to $X in 2021. Over the period under review, imports recorded a significant decrease. The growth pace was the most rapid in 2019 when imports increased by 78%. The level of import peaked at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.

Imports by Country

Malaysia was the largest importing country with an import of around X tons, which recorded 44% of total imports. Kuwait (X tons) held a 26% share (based on physical terms) of total imports, which put it in second place, followed by Japan (15%). The following importers - Iran (X tons), India (X tons), Pakistan (X tons) and Sri Lanka (X tons) - together made up 9.2% of total imports.

From 2012 to 2021, the biggest increases were recorded for Japan (with a CAGR of +32.4%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Japan ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Asia, comprising 37% of total imports. The second position in the ranking was taken by Kuwait ($X), with a 14% share of total imports. It was followed by Malaysia, with a 12% share.

From 2012 to 2021, the average annual growth rate of value in Japan amounted to +61.7%. In the other countries, the average annual rates were as follows: Kuwait (+2.9% per year) and Malaysia (+4.2% per year).

Import Prices by Country

In 2021, the import price in Asia amounted to $X per ton, increasing by 35% against the previous year. Overall, the import price, however, continues to indicate a abrupt shrinkage. The most prominent rate of growth was recorded in 2017 when the import price increased by 47%. The level of import peaked at $X per ton in 2012; however, from 2013 to 2021, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was India ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Japan (+22.1%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :